These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey: estimate of percutaneous first-pass metabolism. Wester RC; Noonan PK; Smeach S; Kosobud L J Pharm Sci; 1983 Jul; 72(7):745-8. PubMed ID: 6411893 [TBL] [Abstract][Full Text] [Related]
3. Analysis, disposition and pharmacokinetics of nitroglycerin. Curry SH; Aburawi SM Biopharm Drug Dispos; 1985; 6(3):235-80. PubMed ID: 3929851 [No Abstract] [Full Text] [Related]
4. Site dependence for topical absorption of nitroglycerin in rats. Horhota ST; Fung HL J Pharm Sci; 1978 Sep; 67(9):1345-6. PubMed ID: 99511 [No Abstract] [Full Text] [Related]
5. Percutaneous absorption of 1,3-dinitroglycerin and a trial of pharmacokinetic analysis. Ogiso T; Iwaki M; Kanokogi A; Terao Y Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2829-33. PubMed ID: 2127557 [TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical considerations of transdermal nitroglycerin delivery: the various approaches. Chien YW Am Heart J; 1984 Jul; 108(1):207-16. PubMed ID: 6428207 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of nitroglycerin ointments in the rabbit. Ritschel WA; Ritschel-Beurlin G; Grummich K Arzneimittelforschung; 1980; 30(3):432-5. PubMed ID: 6770874 [TBL] [Abstract][Full Text] [Related]
9. [Hemodynamic effects of per os and percutaneous administration of nitroglycerin in severe cardiac insufficiency. Comparative study with intravenous nitroglycerin]. Metzger JP; Zannier-Marzari D; Montgermont P; N'Koua JL; Baubion N; Le Pailleur C; Vacheron A Therapie; 1985; 40(3):173-6. PubMed ID: 3925587 [No Abstract] [Full Text] [Related]
11. Topical administration of progestational steroids in the eye and nose--a rapid absorption to the blood. Ohman L; Hahnenberger R; Johansson ED Contraception; 1978 Aug; 18(2):171-80. PubMed ID: 99284 [No Abstract] [Full Text] [Related]
12. Use of transdermal glyceryl trinitrate to reduce failure of intravenous infusion due to phlebitis and extravasation. Wright A; Hecker JF; Lewis GB Lancet; 1985 Nov; 2(8465):1148-50. PubMed ID: 2865615 [TBL] [Abstract][Full Text] [Related]
13. Influence of the method of application on pharmacokinetics of nitroglycerin from ointment in humans. Sved S; McLean WM; McGilveray IJ J Pharm Sci; 1981 Dec; 70(12):1368-9. PubMed ID: 6798193 [TBL] [Abstract][Full Text] [Related]
15. Frequency of application on percutaneous absorption of hydrocortisone. Wester RC; Noonan PK; Maibach HI Arch Dermatol; 1977 May; 113(5):620-2. PubMed ID: 404969 [TBL] [Abstract][Full Text] [Related]
16. Disposition of nitroglycerin in the beagle dog after intravenous and buccal administration. Ritschel WA; Shaaya AN; Tan HS Methods Find Exp Clin Pharmacol; 1985 Jun; 7(6):307-13. PubMed ID: 3932795 [TBL] [Abstract][Full Text] [Related]
17. Influence of skin site on bioavailability of nitroglycerin ointment in congestive heart failure. Moe G; Armstrong PW Am J Med; 1986 Nov; 81(5):765-70. PubMed ID: 3096133 [TBL] [Abstract][Full Text] [Related]